AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2018
Jun 1, 2018
34983_dirs_2018-05-31_ccf089dd-dd75-464e-b312-2979645b7a59.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20
Reporting Person: Spissinger Allan Horst (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-05-31 | Stock Options | $1.53 | A | 300000 | Acquired | 2023-05-31 | Common Shares (300000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 69166 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $0.37 | 2022-06-01 | Common Shares (200000) | 200000 | Direct |
| Stock Options | $0.83 | 2022-12-01 | Common Shares (200000) | 400000 | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29
Regulatory Filings
2025
Dec 19